Compare NOCIL with Similar Stocks
Dashboard
Poor long term growth as Operating profit has grown by an annual rate -5.23% of over the last 5 years
The company has declared Negative results for the last 5 consecutive quarters
With ROE of 3.6, it has a Very Expensive valuation with a 1.4 Price to Book Value
Falling Participation by Institutional Investors
Consistent Underperformance against the benchmark over the last 3 years
Stock DNA
Specialty Chemicals
INR 2,594 Cr (Small Cap)
38.00
37
1.38%
-0.16
3.56%
1.37
Total Returns (Price + Dividend) 
Latest dividend: 2 per share ex-dividend date: Jul-30-2025
Risk Adjusted Returns v/s 
Returns Beta
News

NOCIL Ltd Surges on Heavy Value Trading Despite Strong Sell Rating
NOCIL Ltd, a small-cap player in the specialty chemicals sector, witnessed a remarkable surge in trading value and volume on 23 Mar 2026, outperforming its sector and broader market indices despite a prevailing negative sentiment in the chemicals industry. The stock’s sharp intraday gains and elevated turnover highlight significant institutional interest and active large order flow, signalling a potential shift in investor perception amid cautious market conditions.
Read full news article
NOCIL Ltd Surges on Exceptional Volume Amid Sector Weakness
NOCIL Ltd, a small-cap player in the specialty chemicals sector, witnessed a remarkable surge in trading volume on 23 March 2026, with over 2.91 crore shares changing hands. Despite a strong intraday price rally, the stock remains under pressure from a recent downgrade, reflecting a complex interplay of market enthusiasm and cautious investor sentiment.
Read full news article
NOCIL Ltd Surges 8.03% to Day's High of Rs 157.5 — Outperforms Sector by 9.9 Percentage Points
While the Sensex declined sharply by 1.89% on 23 Mar 2026, NOCIL Ltd surged 8.03%, touching an intraday high of Rs 157.5. This 9.9-percentage-point outperformance over the Chemicals sector’s 2.06% fall highlights a distinctly stock-specific rally rather than a market-wide uplift.
Read full news article Announcements 
Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015
17-Mar-2026 | Source : BSEDisclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements)Regulation2015
Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015
16-Mar-2026 | Source : BSEDisclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements )Regulations 2015
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011.
07-Mar-2026 | Source : BSEThe Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on March 06 2026 for Hrishikesh Arvind Mafatlal as a Trustee of (Gurukripa Trust)
Corporate Actions 
No Upcoming Board Meetings
NOCIL Ltd has declared 20% dividend, ex-date: 30 Jul 25
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Dec 2025
Shareholding Compare (%holding) 
Non Institution
18.6633
Held by 9 Schemes (5.68%)
Held by 60 FIIs (4.47%)
Hrishikesh Arvind Mafatlal(as A Trustee Of Gurukripa Trust) (18.16%)
Icici Prudential Retirement Fund-pure Equity Plan (3.56%)
45.19%
Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ
QoQ Growth in quarter ended Dec 2025 is -1.47% vs -4.66% in Sep 2025
QoQ Growth in quarter ended Dec 2025 is -23.68% vs -29.78% in Sep 2025
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is -10.63% vs -1.70% in Sep 2024
Growth in half year ended Sep 2025 is -57.54% vs 12.58% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'25
YoY Growth in nine months ended Dec 2025 is -7.63% vs -3.23% in Dec 2024
YoY Growth in nine months ended Dec 2025 is -52.94% vs -10.24% in Dec 2024
Annual Results Snapshot (Consolidated) - Mar'25
YoY Growth in year ended Mar 2025 is -3.60% vs -10.63% in Mar 2024
YoY Growth in year ended Mar 2025 is -22.66% vs -10.83% in Mar 2024






